Should you pause your diabetes drug before heart surgery?
Part of Heart & circulation clinical trials.
This trial compares stopping or continuing your diabetes medication (SGLT-2 inhibitor) before heart surgery to see which approach is safer and better. It may help you and your doctor decide the best way to manage your medication around your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for heart surgery that uses a heart-lung machine.
- You have been taking an SGLT-2 inhibitor (like empagliflozin or dapagliflozin) for at least 4 weeks.
- You have heart failure with a weakened heart muscle (ejection fraction below 50%).
- You do not have severe kidney disease (filter rate below 25).
- Your surgery is at least 3 days away.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a diabetes medication called dapagliflozin can help improve how well the right side of your heart works after off-pump coronary artery bypass grafting surgery (a way to reroute blood around blocked heart arteries). The goal is to see if this drug reduces strain on your heart during recovery.
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
This trial tests whether dapagliflozin, a diabetes drug that also helps the heart, can improve exercise ability and heart function in people who have had the Fontan procedure for a single ventricle heart defect.
This study tests whether drinking a carbohydrate drink before gastrointestinal surgery is safe and helpful for people with type 2 diabetes. It uses a continuous glucose monitor to track blood sugar levels around surgery.
This study tests different blood sugar targets during heart surgery that uses a heart-lung machine for older adults with diabetes, to see which range may reduce complications. It focuses on people having combined heart procedures, like bypass plus valve surgery.
This study looks at how starting an SGLT2 inhibitor (a diabetes medicine) around the time of a heart attack affects heart outcomes and heart muscle changes over time. It may help you and your care team understand whether this timing is beneficial after a PCI procedure.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.